Cargando…
Population pharmacokinetic analysis of RO5459072, a low water‐soluble drug exhibiting complex food–drug interactions
AIMS: RO5459072, a cathepsin‐S inhibitor, Biopharmaceutics Classification System class 2 and P‐glycoprotein substrate, exhibited complex, nonlinear pharmacokinetics (PK) while fasted that seemed to impact both the absorption and the disposition phases. When given with food, all nonlinearities disapp...
Autores principales: | Kratochwil, Nicole A., Stillhart, Cordula, Diack, Cheikh, Nagel, Sandra, Al Kotbi, Nada, Frey, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451882/ https://www.ncbi.nlm.nih.gov/pubmed/33576513 http://dx.doi.org/10.1111/bcp.14771 |
Ejemplares similares
-
Pharmacodynamic Monitoring of RO5459072, a Small Molecule Inhibitor of Cathepsin S
por: Theron, Michel, et al.
Publicado: (2017) -
Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective
por: Riedmaier, Arian Emami, et al.
Publicado: (2020) -
Physiologically Based Biopharmaceutics Modeling of Food Effect for Basmisanil: A Retrospective Case Study of the Utility for Formulation Bridging
por: Belubbi, Tejashree, et al.
Publicado: (2023) -
A Baseline Score to Predict Response to Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration
por: Diack, Cheikh, et al.
Publicado: (2021) -
Evaluation of the safety, tolerability, and pharmacokinetics of RO7049389 in healthy Chinese volunteers
por: Wu, Xiaojie, et al.
Publicado: (2021)